[Clinical study of the termination of early pregnancy by administration of DL-15 methyl prostaglandin F2a methyl ester in combination with testosterone propionate or mestrinone (R2323)].
D000028:Abortion, Induced; D001695:Biology; D002264:Carboxylic Acids; D055598:Chemical Phenomena; D002621:Chemistry; D003267:Contraception; D004703:Endocrine System; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D009930:Organic Chemicals; D010570:Pessaries; D010827:Physiology; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011453:Prostaglandins; D012098:Reproduction; D013089:Spermatocidal Agents
D002264:Carboxylic Acids; D009930:Organic Chemicals; D011453:Prostaglandins; D013089:Spermatocidal Agents
Abortion, Induced; Biology; Carboxylic Acids; Contraception; Contraceptive Methods--administraction and dosage; Endocrine System; Evaluation; Family Planning; Fertility Control, Postconception; Ingredients And Chemicals; Organic Chemicals; Physiology; Pregnancy; Pregnancy, First Trimester; Prostaglandins--administraction and dosage; Reproduction; Vaginal Spermicides--administraction and dosage; Vaginal Suppository--administraction and dosage